The most notable overall observation is the lack of evidence to support a significant association between ERBB2 single nucleotide polymorphisms and breast cancer initiation, despite the information supporting its role in breast cancer progression [25–27]. This evidence concerns the gene ERBB2 and breast carcinoma.